Allurion Technologies
ALUR · Natick, MA
Works in Metabolic & endocrine
Allurion Technologies is a clinical trial sponsor based in Natick, MA, listed as ALUR. It has 2 active clinical trials with 1,250 planned participants, in Metabolic & endocrine. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · ALUR
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Allurion Technologies
Allurion Technologies is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 1,250 planned participants, in Metabolic & endocrine. Since 2021 it has completed 2 trials and stopped 0 early.
Allurion Technologies is based in Natick, MA and is listed as ALUR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Allurion Technologies; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-06.
Approve Suite is not affiliated with Allurion Technologies.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.